Alopecia aerate and androgenic

Clinical evidence with Regenkit A-PRP technology

Androgenetic alopecia

RegenPRP® increases the hair density of patients treated for androgenetic alopecia.1-3

In a prospective study1, 20 patients were treated with RegenPRP intradermal injections for androgenetic alopecia.

  • Three treatment sessions were performed with an interval of 21 days and a booster session at 6 months following the onset of therapy.
  • Clinical benefits were evaluated in terms of hair density.
Results

There was a significant increase in hair density at 3 months that was still significant at 6 months and one year following treatment as compared to baseline levels (before treatment).

  • Patients were satisfied with the treatment, giving an average score of 7.1 on a scale of 1-10.
  • No (major) adverse effects were noted.

graph result androgenetic alopecia

Data from Gkini et al.1 showing the hair density of patients treated with RegenPRP. Mean±SD, *** p<0.001 compared to baseline (BL)
data from betsi  ANDROGENETIC ALOPECIA
Data from Betsi et al.4 using the hair pull test to measure hair loss in patients treated with RegenPRP injections every 2 weeks for a total of six sessions. Mean±SEM, ** p<0.01 compared to baseline (BL)
Conclusion

RegenPRP® treatment restores hair loss to normal levels.4

RegenPRP® can be used in combination with other hair restoration modalities (minoxidil, finasteride).2

In a retrospective study, Ho et al.2 evaluated 24 patients receiving injections of RegenPRP.

  • All study patients used topical 5% minoxidil and 83.3% (20/24) used oral antiandrogen medications.
Results
  • A positive response to RegenPRP was seen in 70.8% (17/24) of patients, as early as 2 months after the initial injections.
  • These results demonstrate real-world outcomes and help patients to make informed decisions when choosing treatment options for hair loss.
Conclusion

RegenPRP promotes the regeneration of the hair bulb by increasing the blood supply and enhancing follicular cell proliferation, resulting in stronger, denser, and richer hair.1-4

about

Androgenetic alopecia

Platelet-rich plasma preparation and intradermal
injection for alopecia indications

Bibliography

  1. Gkini MA, Kouskoukis AE, Tripsianis G, Rigopoulos D, Kouskoukis K. Study of platelet-rich plasma injections in the treatment of androgenetic alopecia through an one-year period. Journal of cutaneous and aesthetic surgery. 2014;7(4):213-9.
  2. Ho A, Sukhdeo K, Lo Sicco K, Shapiro J. Trichologic response of platelet-rich plasma in androgenetic alopecia is maintained during combination therapy. J Am Acad Dermatol. 2020;82(2):478-9.
  3. Juhasz MLW, Sukhdeo K, Lo Sicco K, Shapiro J. Stratifying clinical response to adjuvant platelet-rich plasma in patients with androgenetic alopecia. The British journal of dermatology. 2020;183(3):580-2.
  4. Betsi E-E, Germain E, Kalbermatten DF, Tremp M, Emmenegger V. Platelet-rich plasma injection is effective and safe for the treatment of alopecia. European journal of plastic surgery. 2013;36(7):407-12.

Our products

Filter by:
RegenACR
Regenkit A PRP
Regenkit A PRP

Contact Regenlab

Now is the time to change your patient’s life. Browse ressources and
get connected to treatment that is right for them.

For more information on our products, please contact us by clicking on the button below:

picto

Our Regional offices are
located in

  • New York (USA)
  • Montréal (Canada)
  • Venice (Italy)
  • Munich (Germany)
  • Paris (France)
  • Dubai (U.A.E.)
  • Beijing (China)
  • Istanbul (Turkey)